A patient who stopped antihypertensive therapy due to concerns about sexual function should be informed that:

Prepare for the NLN Pharmacology Test. Practice with flashcards and multiple choice questions, complete with hints and explanations. Ace your exam with confidence!

Multiple Choice

A patient who stopped antihypertensive therapy due to concerns about sexual function should be informed that:

Explanation:
When a patient is concerned about sexual function, the best approach is to explain that there are antihypertensive options that can maintain blood pressure control with less impact on sexual function. If the current therapy is contributing to sexual dysfunction, switching to an alternative class of medication can often preserve sexual health while keeping BP in a target range. For example, many patients tolerate ACE inhibitors or ARBs well and experience fewer sexual side effects compared with some other classes. The aim is to balance effective hypertension management with quality-of-life considerations, so the patient remains adherent. Abruptly stopping medications poses real risks, such as rebound hypertension that can raise the chance of a stroke or heart attack, which is why continuing therapy and adjusting the regimen is preferred. Side effects may not disappear with continued use, so changing to a different agent is a practical solution.

When a patient is concerned about sexual function, the best approach is to explain that there are antihypertensive options that can maintain blood pressure control with less impact on sexual function. If the current therapy is contributing to sexual dysfunction, switching to an alternative class of medication can often preserve sexual health while keeping BP in a target range. For example, many patients tolerate ACE inhibitors or ARBs well and experience fewer sexual side effects compared with some other classes. The aim is to balance effective hypertension management with quality-of-life considerations, so the patient remains adherent. Abruptly stopping medications poses real risks, such as rebound hypertension that can raise the chance of a stroke or heart attack, which is why continuing therapy and adjusting the regimen is preferred. Side effects may not disappear with continued use, so changing to a different agent is a practical solution.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy